Access Statistics for Patricia M. Danzon

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality 0 0 0 391 0 0 1 1,194
Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets 0 0 1 73 0 0 6 248
Effects of Regulation on Drug Launch and Pricing in Interdependent Markets 0 0 0 245 1 1 3 801
Mandated Employment-Based Health Insurance: Incidence and Efficiency Effects 0 0 0 1 0 0 1 478
Mergers and Acquisitions in the Pharmaceutical and Biotech Industries 0 1 4 1,500 0 4 19 4,603
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement 1 1 1 97 2 2 5 201
Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? 0 1 1 5 0 1 1 13
Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy 0 0 0 0 0 0 0 0
Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances 0 0 1 540 0 0 3 1,979
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand 0 0 1 352 1 3 7 1,141
The Effects of Malpractice Litigation on Physicians' Fees and Incomes 0 0 0 0 0 0 0 673
The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s 0 0 1 294 2 3 4 772
Vaccine Supply: Effects Of Regulation And Competition 0 0 0 22 0 2 4 158
Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context 0 0 1 55 0 0 4 165
Total Working Papers 1 3 11 3,575 6 16 58 12,426
1 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
"Crises" in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market 0 1 2 41 0 2 3 191
A general model of the impact of absenteeism on employers and employees 0 0 0 142 0 4 6 697
A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth 0 0 1 18 0 0 1 62
Alternative Liability Regimes for Medical Injuries 0 0 1 2 0 0 1 17
At what price? 0 0 0 0 0 0 0 1
Comments on "The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions." 0 0 0 0 0 0 0 294
Contingent Fees for Personal Injury Litigation 0 0 1 83 0 2 3 868
Cross-national price differences for pharmaceuticals: how large, and why? 0 0 1 321 1 1 6 735
Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues 0 0 0 14 0 1 4 47
Does Regulation Drive out Competition in Pharmaceutical Markets? 0 0 3 30 1 1 14 1,164
Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion 0 0 2 81 0 1 3 223
Health Care Reform 0 0 0 4 0 1 2 27
Health Insurance and the Growth in Pharmaceutical Expenditures 0 0 0 13 0 0 3 59
Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment 0 0 1 4 0 0 1 247
Hospital `profits': The effects of reimbursement policies 0 0 0 38 0 0 1 140
Liability and liability insurance for medical malpractice 0 0 2 60 0 0 4 184
Liability for Medical Malpractice 0 0 0 198 0 1 4 677
Medical negligence and the NHS: an economic analysis 0 0 0 1 0 0 1 162
Mergers and acquisitions in the pharmaceutical and biotech industries 0 1 3 329 3 6 18 1,078
Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement 0 0 0 6 1 1 1 51
Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? 0 0 0 10 0 0 0 34
Price Cutting in Liability Insurance Markets 0 0 1 110 1 3 4 474
Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU 0 0 3 154 0 3 17 415
Price, Financial Quality, and Capital Flows in Insurance Markets 0 1 2 120 1 2 7 396
Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances 0 2 3 123 3 8 15 593
Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance 0 0 0 77 0 0 0 650
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand 0 0 0 76 0 0 4 450
Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 0 1 2 88 0 2 5 308
Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 0 0 0 7 0 0 0 21
Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 0 0 0 6 0 0 2 50
Separation of the redistributive and allocative functions of government: A public choice perspective 0 0 0 68 0 0 0 463
The Economic Implications of Public Disability Insurance in the United States 0 0 0 46 0 0 0 205
The Effects of Malpractice Litigation on Physicians' Fees and Incomes 0 0 0 53 0 0 0 183
The Frequency and Severity of Medical Malpractice Claims 0 0 0 7 0 1 1 597
The Political Economy of Workers' Compensation: Lessons for Product Liability 0 0 1 10 0 0 1 65
The Swedish patient compensation system: Myths and realities 0 0 0 94 0 0 3 227
The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s 0 1 1 85 1 3 4 353
Tort Liability: A Minefield for Managed Care? 0 0 0 0 0 0 0 232
Tort Reform: The Case of Medical Malpractice 0 0 0 0 0 0 3 458
Vaccine Supply: Effects of Regulation and Competition 0 0 1 26 0 0 2 192
Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context 0 0 0 21 0 0 6 143
Welfare effects of supplementary insurance: a comment 0 0 0 25 0 0 0 73
Worker's Compensation Rate Regulation: How Price Controls Increase Costs 0 0 0 1 0 0 2 430
Total Journal Articles 0 7 31 2,592 12 43 152 13,936


Book File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison 0 0 0 7 1 1 4 63
The Life Cycle of Pharmaceuticals: A Cross-National Perspective 0 0 0 2 1 2 2 33
Trade and Price Differentials for Pharmaceuticals: Policy Options 1 1 3 20 1 3 6 94
Total Books 1 1 3 29 3 6 12 190


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Effects of Regulation on Drug Launch and Pricing in Interdependent Markets 0 0 0 0 0 0 0 1
Liability for medical malpractice 1 1 5 669 3 5 18 3,316
Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand 0 0 0 43 0 2 4 193
Regulation of the Biopharmaceutical Industry 0 0 0 16 0 0 0 23
Regulation of the Pharmaceutical-Biotechnology Industry 1 2 5 160 2 5 12 456
The Effects of Price Regulation on Productivity in Pharmaceuticals 0 0 0 21 0 0 0 69
Total Chapters 2 3 10 909 5 12 34 4,058


Statistics updated 2024-05-04